aTYR PHARMA INC (ATYR): Net Income
-$74.12M
Year ended 2025-12-31
-$60.81M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$74.12M | n/m | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | -$64.02M | n/m | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | -$50.39M | n/m | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | -$45.34M | n/m | 2025-03-13, From 2022-01-01 |
| 2021-12-31 | -$33.77M | n/m | 2024-03-14, From 2021-01-01 |
| 2020-12-31 | -$16.22M | n/m | 2023-03-14, From 2020-01-01 |
| 2019-12-31 | -$16.22M | n/c | 2023-03-14, From 2019-01-01 |
| 2018-12-31 | -$34.52M | n/m | 2021-03-24, From 2018-01-01 |
| 2017-12-31 | -$48.21M | n/m | 2020-03-26, From 2017-01-01 |
| 2016-12-31 | -$57.85M | n/m | 2019-03-26, From 2016-01-01 |
| 2015-12-31 | -$47.97M | n/m | 2018-03-20, From 2015-01-01 |
| 2014-12-31 | -$24.35M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$20.01M | n/a | 2016-03-30, From 2013-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| aTYR PHARMA INC (ATYR) | 2025-12-31 | -$74.12M | n/m |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | -$13.38M | n/m |
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | -$13.84M | n/m |
| AIM ImmunoTech Inc. (AIM) | 2025-12-31 | -$13.96M | n/m |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | -$45.85M | n/m |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | -$45.93M | n/m |
| ImageneBio, Inc. (IMA) | 2025-12-31 | -$45.35M | n/m |
| Entera Bio Ltd. (ENTX) | 2025-12-31 | -$11.44M | n/m |
| Prokidney Corp. (PROK) | 2025-12-31 | -$151.61M | n/m |
Compare ATYR, ZIVO, VIVS, AIM side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗